McMinn Rachel (CIK 1606302) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-30). Recent activity: Sell NGNE (3,352 shares), Buy NGNE (25,900 shares), Buy NGNE (23,900 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | Neurogene Inc. (NGNE) | Chief Executive Officer | Sell | 3,352 | $73,979 |
| 2026-02-24 | Neurogene Inc. (NGNE) | Chief Executive Officer | Buy | 25,900 | $0 |
| 2025-03-28 | Neurogene Inc. (NGNE) | Chief Executive Officer | Buy | 23,900 | $0 |
Source: SEC Form 4 filings · as of 2026-03-30